| The Efficacy of Short-term Administration of Revaprazan on Gastroesophageal Reflux Symptoms: Comparison with Half Dose Esomeprazole, a Pilot Study |
|
Hae Mi Lee, Byung Wook Kim, Joon Sung Kim, Eun Joo Im, Jong In Kim, Bong Koo Kang, Jeong Seon Ji, Bo In Lee, Hwang Choi |
|
Division of Gastroenterology, Department of Internal Medicine, Incheon St. Mary's Hospital, The Catholic University of Korea College of Medicine, Incheon, Korea. gastro@catholic.ac.kr |
| 위식도 역류 증상에 대한 레바프라잔 단기 투여의 증상 빈도 개선 효과: 저용량 에소메프라졸과의 비교 예비 연구 |
|
이해미, 김병욱, 김준성, 임은주 김종인, 강봉구, 지정선, 이보인, 최황 |
|
가톨릭대학교 의과대학 인천성모병원 소화기내과 |
|
|
| Abstract |
BACKGROUND/AIMS
Revaprazan, an acid pump antagonist, is a kind of gastric acid suppressant and is prescribed for the treatment of peptic ulcers and gastritis. However, the efficacy of revaprazan on gastroesophageal reflux symptoms has not been established. The aim of this study was to evaluate the short-term efficacy of revaprazan on gastroesophageal reflux symptoms. MATERIALS AND METHODS: Patients who complained of gastroesophageal reflux symptoms without any specific diseases except gastritis on esophagogastroduodenoscopy were included in this study. Patients were randomized to receive revaprazan 200 mg or esomeprazole 20 mg for 2 weeks. Symptoms were assessed by using the frequency score questionnaire before and after treatment. RESULTS: Fifteen patients received revaprazan and 19 patients received esomeprazole. The changes of the symptom frequency score before and after treatment were 7.0 in revaprazan group and 8.6 in esomeprazole group (P=0.778). CONCLUSIONS: Revaprazan is not inferior to esomeprazole in therapeutic efficacy for gastroesophageal reflux symptoms and is a safe and useful therapeutic agent to reduce the frequency of gastroesophageal reflux symptoms. |
| Key Words:
Revaprazan; Esomeprazole; Gastroesophageal reflux |
|
PDF Links
Full text via DOI
Download Citation
